Rabies vaccine batch check: will every dose protect?
NCT ID NCT07416110
First seen Feb 18, 2026 · Last updated Jun 23, 2026 · Updated 19 times
Summary
This phase 3 trial tests whether three different batches of a rabies vaccine produce the same immune response and are safe. It involves 912 healthy adults aged 18-45. The vaccine is given after a potential rabies exposure to prevent the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RABIES (HEALTHY VOLUNTEERS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mianzhu Municipal Center for Disease Control and Prevention
Deyang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Neijiang Municipal Center for Disease Control and Prevention
Neijiang, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rabies vaccine (Vero cell, freeze-dried)
What this could lead to
If successful, this trial could confirm that different batches of this rabies vaccine work equally well, supporting its widespread use to prevent rabies after exposure.
What could go wrong
This is a consistency trial in healthy volunteers, not a test of real-world rabies prevention. It may not show how the vaccine performs in actual rabies exposures or in other age groups.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.